Levofolinate Calcium

左亚叶酸钙

Report date: 2024/04/26 13:11:11
NME

Base Information

Drug NameLevofolinate Calcium
Drug Alias NameLevofolinate calcium左旋亚叶酸钙Levoleucovorin calcium pentahydrateLevoleucovorin CalciumCalcium levoleucovorin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsCNS Embryonal TumorStomach NeoplasmsColorectal Neoplasms +[5] 
Global Approved IndicationsStomach NeoplasmsColorectal Neoplasms
Approved Indications in ChinaStomach NeoplasmsColorectal Neoplasms
Original Approved Country/TerritoryN/A
Original Approved Date1991/03/09
Country/TerritoryUnited StatesSwedenMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu shengdi Medicine Co LtdTowa Pharmaceutical Co Ltd
Inactive CompaniesActavis LlcThe University Of Texas MD Anderson Cancer CenterAcrotech Biopharma Llc +[4] 
Active IndicationsStomach NeoplasmsColorectal Neoplasms
Inactive IndicationsCNS Embryonal TumorPeritoneal NeoplasmsOsteosarcoma

Other Information

ATC CodeV03AF04
Related LinksWikipediaDrugBankKEGG